Prolonged Paradoxical TB-IRIS: 2 Case Reports and a Review of the Literature
Open Access
- 30 March 2026
- journal article
- case report
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (4) , ofag212
Abstract
Although paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV-TB coinfection is typically thought of as occurring within several months of starting antiretroviral therapy, more prolonged manifestations have been reported. We describe 2 cases in which manifestations of TB-IRIS continued for longer than 1 year after the end of TB treatment and review the literature on prolonged TB-IRIS. These cases are often characterized by a history of extrapulmonary TB and initially low CD4 counts and commonly demonstrate lymphadenitis or abscesses. In the absence of clear consensus around its appropriate management, prolonged TB-IRIS presents a significant diagnostic and therapeutic dilemma.Keywords
Funding Information
- UCSF Biology of Infectious Diseases Training Program (2T32AI007641)
This publication has 63 references indexed in Scilit:
- Post-tuberculosis treatment paradoxical reactionsInfection, 2024
- A teenage girl with altered mental status and paraparesisJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2024
- The use of TNF-α antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature reviewEuropean Journal of Clinical Microbiology & Infectious Diseases, 2023
- TNF activity and T cellsCytokine, 2018
- Incidence and outcomes of paradoxical lymph node enlargement after anti-tuberculosis therapy in non-HIV patientsJournal of Infection, 2013
- Management of the Immune Reconstitution Inflammatory SyndromeCurrent HIV/AIDS Reports, 2012
- Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosisJournal of Infection, 2009
- Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapyJournal of Infection, 2006
- Risk Factors for Development of Paradoxical Response During Antituberculosis Therapy in HIV-Negative PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Clinical Spectrum of Paradoxical Deterioration During Antituberculosis Therapy in Non-HIV-Infected PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002